Subcutaneous DMPA (DMPA-SC) is an innovative injectable contraceptive that can dramatically expand access and choice for women. Led by PATH in partnership with JSI, the DMPA-SC Access Collaborative provides data-driven technical assistance, coordination, and tools to ensure that women and adolescent girls have equitable access to self-injection as one contraceptive option, delivered through informed choice programming. For more information, visit the DMPA-SC Resource Library, DMPA-SC Access Collaborative page, or email FPoptions@path.org.